VistaGen Therapeutics, Inc. is a biotechnology company focused on using proprietary stem cell technologies for drug rescue.

Our integrated stem cell biology platform, Human Clinical Trials in a Test Tube™, is designed to provide an early indication, or prediction, of the potential cardiac toxicity of drug candidates before they are ever tested in humans.

Our stem cell technology is designed to identify new, safer, variants of promising drug candidates. These candidates have been previously “put on the shelf” by pharmaceutical companies due to toxicity concerns, despite positive efficacy data signaling their potential therapeutic benefits. Our goal is to build a diverse drug pipeline of “drug rescue variants” that are as effective as the original drug candidates but without the toxicity that caused them to be put on the shelf in the first place.